Short Interest in BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) Grows By 881.9%

BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNHGet Free Report) saw a large growth in short interest in August. As of August 31st, there was short interest totaling 815 shares, a growth of 881.9% from the August 15th total of 83 shares. Based on an average daily volume of 11,376 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the shares of the company are sold short.

BioForce Nanosciences Price Performance

Shares of BioForce Nanosciences stock traded up $1.68 during trading on Thursday, hitting $8.75. 52,018 shares of the company’s stock traded hands, compared to its average volume of 7,514. The company has a market cap of $333.11 million, a PE ratio of 875.88 and a beta of -0.31. The firm’s fifty day moving average price is $2.76 and its 200 day moving average price is $1.50. BioForce Nanosciences has a twelve month low of $0.18 and a twelve month high of $10.15.

BioForce Nanosciences (OTCMKTS:BFNHGet Free Report) last released its quarterly earnings data on Monday, August 10th. The company reported $0.01 earnings per share (EPS) for the quarter.

BioForce Nanosciences Company Profile

(Get Free Report)

BioForce Nanosciences, Inc develops and markets precision instrumentation and proprietary technologies for the production and application of nanoscale materials. Its core platform employs nozzle-driven electrohydrodynamic processes to generate and deposit nanofibers, nanowires and nanoparticles with tight control over diameter, morphology and spatial arrangement. By tailoring electric field parameters and solution properties, the technology enables reproducible fabrication of structures at the nanometer scale.

The company’s product portfolio includes desktop electrospinning systems for nanofiber fabrication, electrospray modules for nanoparticle synthesis and integrated tools for bioprinting and surface patterning.

Further Reading

Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.